Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients
Clinical trial NCT05769582 · COMPLETED
Trial details
- NCT number
- NCT05769582
- Sponsor
- Memo Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-10
- Primary completion
- 2025-03-19
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.